GYNECOLOGICAL CANCERS

DALL·E 2025-02-12 13.06.02 - A simple and informative cartoon-style illustration of ovaria

Q: What is ovarian cancer?

A: Ovarian cancer is cancer that begins in the ovaries or fallopian tubes. It occurs when abnormal cells grow and form a lump or tumour. Epithelial ovarian cancer is the most common type, arising from the cells that line the ovaries. There are different subtypes of epithelial ovarian cancer, including serous carcinoma, mucinous, endometrioid, and clear-cell cancers.

Q: What symptoms should I watch out for in ovarian cancer?

A: Ovarian cancer is often diagnosed at an advanced stage because early symptoms are subtle. Common symptoms include:

Bloating or abdominal discomfort

Feeling full quickly or difficulty eating

Pelvic pain or pressure

Swollen lymph nodes (groin, armpits, or neck)

Unexplained weight loss or fatigue

If you experience persistent symptoms, it is important to consult a doctor for further evaluation.

Q: How is ovarian cancer diagnosed?

A: The diagnosis of ovarian cancer typically involves several steps:

Physical Examination: Your doctor will check for physical signs of cancer.
Abdominal Ultrasound: This test helps detect any abnormalities in the ovaries.
Blood Tests: The CA-125 test, a tumour marker, may be used to help detect ovarian cancer, though it is not conclusive on its own.
CT Scan: A CT scan helps determine the size and spread of the tumour and plan for surgery.
Surgery: A definitive diagnosis is usually made after surgical exploration, where tissue is collected for a biopsy to confirm the presence of cancer.

Q: How is ovarian cancer treated?

A: Treatment for ovarian cancer depends on the stage of the disease:

Early-stage ovarian cancer is typically treated with surgery to remove the tumour and surrounding tissue. This may involve removing one or both ovaries and sometimes the fallopian tubes and uterus.

Advanced ovarian cancer is treated with a combination of surgery and chemotherapy. Chemotherapy uses drugs to destroy cancer cells and is often used after surgery to kill any remaining cancer cells.

Targeted therapy: In some cases, targeted therapies may be used to block signals that help cancer cells grow. These newer treatments are used based on the cancer's specific characteristics.

Q: How is ovarian cancer staged?

A: Ovarian cancer is staged based on the following factors:

Tumour size and how far it has spread

Involvement of lymph nodes

Whether the cancer has spread beyond the abdominal cavity to other parts of the body (metastasis)

This information helps doctors determine the best course of treatment.

Q: What factors increase my risk for ovarian cancer?

A: Some factors that may increase the risk of ovarian cancer include:

Age: Most cases occur in women over 50, particularly those who have gone through menopause.

Family history: A family history of ovarian or breast cancer increases risk, especially if genetic mutations like BRCA1 or BRCA2 are present.

Genetic mutations: Inherited mutations in genes such as BRCA1, BRCA2, Lynch syndrome, or TP53 can significantly increase the risk.

Reproductive history: Women who have not had children or experienced infertility may have a higher risk.

Hormonal factors: Long-term use of hormone replacement therapy (HRT) or oral contraceptives can influence risk.

Q: How can I reduce my risk of ovarian cancer?

A: While there is no surefire way to prevent ovarian cancer, the following steps may lower your risk:

Birth control: Oral contraceptives have been shown to lower the risk of ovarian cancer.

Pregnancy and breastfeeding: These factors may reduce the risk of ovarian cancer.

Genetic testing and counseling: If you have a family history of ovarian or breast cancer, genetic testing may help identify if you carry mutations that increase your risk, allowing for preventive measures or early detection strategies.

Surgery: Women with a high genetic risk (e.g., BRCA mutations) may opt for preventive surgery, such as removing the ovaries and fallopian tubes.

Q: Are there any recent advancements in ovarian cancer treatment?

A: Yes, recent advancements include:

Targeted therapies: Drugs like PARP inhibitors (e.g., olaparib, niraparib) have been shown to be effective in treating ovarian cancer, especially in women with BRCA mutations.

Immunotherapy: There is growing research into immunotherapies that help boost the immune system to fight cancer. Drugs like nivolumab and pembrolizumab are being studied for use in ovarian cancer.

Genetic testing: Personalized treatments based on genetic mutations are becoming more common. For example, women with mutations in the BRCA genes may benefit from targeted treatments like PARP inhibitors.

Q: What is the prognosis for ovarian cancer?

A: The prognosis for ovarian cancer depends on several factors, including the stage at diagnosis, the patient's overall health, and how well the cancer responds to treatment. Early-stage cancers have a better chance of successful treatment, while advanced stages may require ongoing treatment to manage the disease.

Survival rates have improved with advances in chemotherapy, targeted therapies, and early detection methods

Q: How is Stage I epithelial ovarian cancer treated?

A: For women diagnosed with Stage I epithelial ovarian cancer, surgery is typically the first step to remove the tumour. However, if the cancer is classified as intermediate or high risk for recurrence, chemotherapy is often recommended after surgery. This helps to reduce the risk of the cancer coming back.

Q: How is locally advanced or metastatic epithelial ovarian cancer treated?

A: Women with Stage II, III, or IV epithelial ovarian cancer typically undergo chemotherapy after surgery. The standard chemotherapy regimen consists of two drugs:

Paclitaxel

Carboplatin

This combination is effective for many patients, but if a patient has an allergy to paclitaxel or cannot tolerate it, docetaxel or pegylated liposomal doxorubicin can be used as alternatives in combination with carboplatin.

Additionally, for women with Stage III B, III C, or IV ovarian cancer, a targeted drug called bevacizumab may be added to the chemotherapy regimen to help control the cancer.

Q: How is recurrent epithelial ovarian cancer treated?

A: For women whose ovarian cancer returns (recurrence), chemotherapy is usually the main treatment. The drugs and regimen depend on the rate of recurrence and how sensitive the cancer is to previous treatments.

Bevacizumab may be given in combination with chemotherapy or as a single-agent therapy if the tumour has relapsed.

A newer targeted treatment called olaparib is an option for women whose cancer is positive for BRCA1 or BRCA2 mutations and has responded to platinum-based chemotherapy. Olaparib helps maintain the response to treatment for as long as possible.

Niraparib, another targeted therapy, has been recently approved for maintenance therapy in women who are responding to platinum-based chemotherapy.

Q: How often will I need follow-up visits after my treatment for ovarian cancer?

A: After completing treatment, you will typically see your doctor every 3 months for the first two years. After that, visits are usually scheduled every 6 months.

During these visits, your doctor will:

Perform an examination

Conduct a pelvic examination

Request blood tests

Order a CT scan or PET-CT scan to check for any signs of recurrence and decide on any further treatment if needed.

Q: What happens if my ovarian cancer comes back after treatment?

A: If your cancer returns, your doctor will assess how quickly the cancer has returned and how sensitive it is to previous treatments. Depending on this, chemotherapy or other treatments, such as bevacizumab, olaparib, or niraparib, may be used to control the disease and maintain your quality of life.

Q: Are there any recent advancements in the treatment of ovarian cancer?

A: Yes, there have been significant advancements in ovarian cancer treatment, particularly with targeted therapies:

Olaparib: This PARP inhibitor has shown promise for women with BRCA1/BRCA2 mutations and is used as maintenance therapy after platinum-based chemotherapy.

Niraparib: This is another PARP inhibitor approved for maintenance therapy in women responding to platinum-based chemotherapy.

Bevacizumab: This targeted drug can be added to chemotherapy for patients with advanced ovarian cancer to help reduce the risk of recurrence.

Q: Why is chemotherapy used in the treatment of ovarian cancer?

A: Chemotherapy is used in ovarian cancer to destroy cancer cells and prevent the disease from spreading. For advanced stages or recurrent ovarian cancer, chemotherapy helps shrink the tumour, control symptoms, and prevent the disease from coming back. The most commonly used drugs are paclitaxel and carboplatin.

CERVICAL CANCER

Q: What is cervical cancer?

A: Cervical cancer forms in the tissues of the cervix, which is the lower part of the uterus that connects to the vagina. The primary cause of cervical cancer is infection with certain types of human papillomavirus (HPV), a virus that is transmitted through sexual contact.

Q: Is cervical cancer preventable?

A: Yes, cervical cancer can often be prevented. HPV vaccines are available that provide protection against the strains of HPV that are most likely to cause cervical cancer. These vaccines can significantly reduce the incidence of high-grade cervical abnormalities that can develop into cancer.

Q: What are the symptoms of cervical cancer?

A: Early cervical cancer often has no symptoms. As the disease progresses, symptoms may include:

Abnormal vaginal bleeding (e.g., after sex or between periods)

Pelvic pain

Vaginal discharge

Pain during sex

If you experience any of these symptoms, it's important to consult a healthcare provider for evaluation.

Q: How is cervical cancer diagnosed?

A: Diagnosis of cervical cancer involves:

Clinical examination

Colposcopy: An examination using a special magnifying instrument to closely examine the cervix.

Biopsy: Taking a small tissue sample to check for cancer cells.

Additional tests like CT scans, MRI, and PET scans may be used to determine the cancer’s stage and whether it has spread.

Q: How is cervical cancer staged?

A: Cervical cancer is staged based on:

Tumour size

Involvement of lymph nodes

Whether the cancer has spread to other parts of the body

Staging helps determine the most appropriate treatment plan.

Q: How is cervical cancer treated?

A: Treatment depends on the size, location, and stage of the cancer. It may include:

Surgery: The main treatment for early-stage cervical cancer, usually involving a hysterectomy (removal of the uterus).

Chemoradiotherapy: A combination of chemotherapy and radiotherapy for advanced stages.

Chemotherapy: Using drugs to kill cancer cells, often in advanced or metastatic disease.

Radiotherapy: High-energy radiation used to kill cancer cells.

Targeted therapies: Newer treatments that target specific cancer cells.

Q: What is non-invasive cervical intraepithelial neoplasia (CIN), and does it need treatment?

A: CIN is a condition where cells in the cervix show abnormal changes that could develop into cervical cancer.

Non-invasive CIN may not require treatment.

Treatment (e.g., loop electrosurgical excision or conisation) may be recommended to remove the abnormal cells in some cases to prevent progression to cancer.

Q: How is early-stage cervical cancer treated?

A: For early-stage invasive cervical cancer, surgery is usually the primary treatment. This may involve:

Hysterectomy (removal of the uterus)

Pelvic lymph node removal

For women at high risk of recurrence, adjuvant chemoradiotherapy may be recommended.

Fertility-sparing options, like a trachelectomy (removal of the cervix while preserving the uterus), may be available for women who wish to have children in the future.

Q: How is locally advanced cervical cancer treated?

A: Locally advanced cervical cancer is typically treated with a combination of chemoradiotherapy using cisplatin. In some cases, neoadjuvant chemotherapy (chemotherapy before surgery) may be used to shrink the tumour, followed by surgery.

Q: What is the treatment for metastatic cervical cancer?

A: For metastatic cervical cancer, chemotherapy (such as paclitaxel and cisplatin) is usually combined with a targeted therapy called bevacizumab. Palliative radiotherapy may also be used to manage symptoms arising from metastases.

Q: How is recurrent cervical cancer treated?

A: If cervical cancer recurs, treatment will depend on the extent of the recurrence:

If the recurrence is confined to a single site in the pelvis, radiotherapy or pelvic exenteration (removal of pelvic organs) may be considered.

For distant recurrences, chemotherapy with or without targeted therapy is used.

Q: How often should I see my doctor after cervical cancer treatment?

A: Follow-up appointments are typically scheduled:

Every 3-6 months for the first two years

Every 6-12 months after 3 years

Annually after 5 years

During these visits, your doctor will perform a pelvic examination, and you may also undergo a CT or PET/CT scan to check for any recurrence of cancer.

Q: How can support groups help me after cervical cancer treatment?

A: Support groups provide a place for patients and their families to share experiences, receive emotional support, and gain valuable information on coping with the physical and emotional aspects of the disease and treatment. These groups can be an essential part of the recovery process.

ENDOMETRIAL CANCER

Q: What is endometrial cancer?

A: Endometrial cancer is a type of cancer that begins in the endometrium, the lining of the uterus. It is the most common type of uterine cancer. The cancer typically starts in the glandular cells of the endometrium and can spread to surrounding tissues or organs.

Q: What causes endometrial cancer?

A: The exact cause of endometrial cancer is not fully understood, but several risk factors increase the likelihood of developing this cancer, including:

Obesity

Hormonal imbalances (e.g., excess estrogen without enough progesterone)

Age (most commonly diagnosed in women over 50)

Family history (genetic syndromes like Lynch syndrome may increase risk)

Diabetes

High blood pressure

Estrogen replacement therapy (if not balanced with progesterone)

Q: What are the early symptoms of endometrial cancer?

A: Early-stage endometrial cancer often has symptoms. The most common symptom is:

Abnormal vaginal bleeding, especially after menopause or between periods.

Other symptoms may include:

Pelvic pain

Unusual vaginal discharge

Painful urination

Pain during intercourse

If you experience any of these symptoms, it is important to consult a healthcare provider for evaluation.

Q: How is endometrial cancer diagnosed?

A: Diagnosing endometrial cancer involves several steps:

Pelvic examination: Your doctor will physically check for abnormalities.
Transvaginal ultrasound: A scan to check the thickness of the endometrial lining.
Endometrial biopsy: A sample of the endometrial tissue is taken to check for cancer cells.
Hysteroscopy: A thin tube with a camera is inserted into the uterus to directly view the lining.
Imaging tests (CT scan, MRI, or PET scan) may be used to determine the stage and whether the cancer has spread.

Q: How is endometrial cancer staged?

A: Endometrial cancer is staged based on its size, the extent to which it has spread, and whether lymph nodes or distant organs are affected. The stages are:

Stage I: Cancer is confined to the uterus.

Stage II: Cancer has spread to the cervix.

Stage III: Cancer has spread to the vagina, ovaries, or nearby lymph nodes.

Stage IV: Cancer has spread to distant organs, such as the bladder, intestines, or lungs.

The stage helps determine the treatment options.

Q: What is the standard treatment for endometrial cancer?

A: The treatment for endometrial cancer depends on the stage of the disease, the patient's general health, and other factors. Common treatments include:

Surgery: The main treatment for early-stage endometrial cancer. This often involves a hysterectomy (removal of the uterus) and may include removal of the ovaries, fallopian tubes, and nearby lymph nodes.

Radiotherapy: High-energy radiation to kill cancer cells, used for patients with more advanced disease.

Chemotherapy: Use of drugs to kill cancer cells, typically used in advanced stages or when the cancer has spread.

Hormone therapy: For women with estrogen receptor-positive cancers, hormone therapy (e.g., progestin) may be used to block the action of estrogen and slow the growth of the cancer.

Targeted therapy and immunotherapy: Newer treatments that specifically target cancer cells or boost the immune system's ability to fight the cancer. Drugs like lenvatinib and pembrolizumab have shown promise for certain advanced cases.

Q: How is early-stage endometrial cancer treated?

A: For early-stage endometrial cancer (Stage I or II), treatment usually involves surgery to remove the uterus (hysterectomy) along with the ovaries and fallopian tubes. In some cases, radiation therapy is recommended, especially if the cancer has spread beyond the uterus.

Q: What treatments are available for advanced endometrial cancer?

A: For advanced or metastatic endometrial cancer (Stage III or IV), the treatment approach often includes:

Surgery to remove as much of the tumor as possible.

Chemotherapy (often a combination of drugs like carboplatin and paclitaxel) to treat cancer that has spread.

Radiotherapy to shrink tumors and relieve symptoms.

Targeted therapy: Drugs like lenvatinib and pembrolizumab (an immune checkpoint inhibitor) can be used, especially for cancers with specific genetic mutations.

These therapies are used to control the cancer, reduce symptoms, and improve quality of life.

Q: How often will I need follow-up appointments after treatment for endometrial cancer?

A: After treatment, follow-up appointments are essential to monitor for recurrence or complications. Typically, you will be seen by your doctor:

Every 3-6 months for the first 2 years after treatment.

Every 6-12 months after 3 years.

Annually after 5 years.

During these visits, your doctor will conduct a physical examination, pelvic exams, and may order imaging tests (e.g., CT or MRI) to check for signs of cancer recurrence.

Q: What happens if endometrial cancer comes back?

A: If endometrial cancer recurs, the treatment will depend on where the cancer has come back and the previous treatments used. Options may include:

Surgery (if the cancer is localized)

Chemotherapy or radiotherapy for recurrences that involve other organs

Hormonal therapy or targeted therapies for certain types of cancer that are resistant to other treatments

Q: Are there any lifestyle changes that can reduce the risk of endometrial cancer?

A: Yes, several lifestyle factors can help reduce the risk of endometrial cancer:

Maintain a healthy weight

Regular physical activity

Managing diabetes and high blood pressure

Using hormonal birth control (which reduces the risk of endometrial cancer)

Limiting the use of estrogen-only hormone replacement therapy (without progesterone)